Justin Brandler is a Gastroenterology physician. OpenAlex indexes 30 publications with 338 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1100 9th Ave
Ms:c3-Gas
Seattle, WA 981012756
Telephone
206-223-2319Provider last certified this registry record 26 Aug 2022.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI US SERVICES INC.Program year20252 payments
- Boston Scientific CorporationProgram year20231 payment
- Enterra Medical, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.8%Osmotic Laxative34.9%Gavilyte-G45%Peg-3350 And Electrolytes34%Gavilyte-C21%Part D≥118 patientsSerotonin-3 Receptor Antagonist27%Ondansetron Hcl100%Part D≥200 patients+ 6 more classes in this area
Nervous system
12.5%SNRI5.5%Duloxetine Hcl100%Part D≥16 patientsGabapentinoids3%Pregabalin100%Part D<11 patients+ 2 more classes in this area
Blood & clotting
1.7%Solutions for parenteral nutrition1.7%Peg 3350-Electrolyte100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life
Clinical Gastroenterology and Hepatology
2021 - Randomised study: effects of the 5‐HT<sub>4</sub> receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis
Alimentary Pharmacology & Therapeutics
2021 - Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial
American Journal of Physiology-Gastrointestinal and Liver Physiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”